MTOR and breast carcinoma: Therefore, we sought to understand if PTEN C-terminal tail phosphorylation was altered in breast cancer cell lines after exposure to the PI3Kis BYL719 (PI3K), BEZ235 (pan-PI3K/mTOR), or GDC-0941 (pan-PI3K).